| Literature DB >> 26100969 |
Anders Hjerpe1, Valeria Ascoli2, Carlos W M Bedrossian3, Mathilde E Boon4, Jenette Creaney5, Ben Davidson6, Annika Dejmek7, Katalin Dobra1, Ambrogio Fassina8, Andrew Field9, Pinar Firat10, Toshiaki Kamei11, Tadao Kobayashi12, Claire W Michael13, Sevgen Önder14, Amanda Segal15, Philippe Vielh16.
Abstract
OBJECTIVE: To provide practical guidelines for the cytopathologic diagnosis of malignant mesothelioma. DATA SOURCES: Cytopathologists with an interest in the field involved in the International Mesothelioma Interest Group (IMIG) and the International Academy of Cytology (IAC) contributed to this update. Reference material includes peer-reviewed publications and textbooks. RATIONALE: This article is the result of discussions during and after the IMIG 2012 conference in Boston, followed by thorough discussions during the 2013 IAC meeting in Paris. Additional contributions have been obtained from cytopathologists and scientists who could not attend these meetings, with final discussions and input during the IMIG 2014 conference in Cape Town.Entities:
Keywords: Ancillary testing; Cytology; Guidelines; International Mesothelioma Interest Group; Malignant mesothelioma
Mesh:
Year: 2015 PMID: 26100969 DOI: 10.1002/dc.23271
Source DB: PubMed Journal: Diagn Cytopathol ISSN: 1097-0339 Impact factor: 1.582